Capsule Summary Slidesets

Share

Program Content

Activities

  • Avatrombopag In ITP
    Updated Results From a Randomized Phase III Trial of Avatrombopag in Patients With Chronic ITP
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 11, 2019

    Expires: December 09, 2020

  • BELIEVE Subanalysis
    BELIEVE Subanalysis: Evaluation of Responders With Transfusion-Dependent β-Thalassemia to Luspatercept
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 17, 2019

    Expires: December 15, 2020

  • Northstar-3 (HGB-212)
    Interim Results From the Phase III Northstar-3 (HGB-212) Study of Betibeglogene Autotemcel in Patients With Severe Transfusion-Dependent β-Thalassemia
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 17, 2019

    Expires: December 15, 2020

  • PRN1008 in ITP
    Phase I/II Evaluation of Novel BTKi PRN1008 in R/R Primary or Secondary Immune Thrombocytopenia
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 10, 2019

    Expires: December 08, 2020

  • Sutimlimab in Chronic ITP
    Phase I Trial of Sutimlimab to Inhibit Classical Complement Pathway in Patients With Multi-Refractory Chronic Immune Thrombocytopenia
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 18, 2019

    Expires: December 16, 2020

  • CARDINAL: Sutimlimab for CAD
    CARDINAL: Phase III Study of Sutimlimab in Patients With Cold Agglutinin Disease and a Recent History of Transfusion
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 15, 2019

    Expires: December 13, 2020

  • SCD: <i>BCL11A</i> Gene Therapy
    Pilot Feasibility Study of BCL11A as Gene Therapy Target in Sickle Cell Disease
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 13, 2019

    Expires: December 11, 2020

Provided by

ProCE Banner

Supporters

AstraZeneca

Celgene

Dova Pharmaceuticals

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Karyopharm Therapeutics

Loxo Oncology subsidiary of Eli Lilly

Pharmacyclics an AbbVie Company